Literature DB >> 11578853

Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain.

M Taniguchi1, Y Shinoda, H Ninomiya, M T Vanier, K Ohno.   

Abstract

Niemann-Pick disease type C (NPC) is a progressive neurodegenerative disorder with characteristic storage of glycolipids in the brain. This study investigated cellular origin and temporal changes of monosialoganglioside storage in the Balb/c npc(nih) mouse brain by immunohistochemistry. Anti-GM1 gave positive staining of the hippocampus, thalamus, cerebellar molecular and Purkinje cell layers in the 3-week old NPC mouse brain and in general, the staining progressively diminished in an age-dependent manner. Anti-GM2 gave positive staining of the hippocampus, thalamus, cerebellar granule cell layer and brainstem nuclei in the 3-week old NPC mouse brain. In contrast to GM1, GM2 staining in these regions, except for the hippocampus, progressively augmented in an age-dependent manner. Double labeling experiments with antibodies against glial fibrillary acidic protein and lysozyme showed localization of GM1 and GM2 in reactive astrocytes and macrophages, respectively. Thus in the NPC mouse brain, GM1 accumulated primarily in neurons and astrocytes whereas GM2 accumulated primarily in neurons and macrophages. Temporal profiles of storage were different from each other and depended on the cell type, presumably reflecting both developmental changes and progression of the disease process. We also investigated subcellular sites of storage in primary-cultured Purkinje cells from the neonatal NPC mouse by immunocytochemistry. In NPC Purkinje cells, GM1 accumulated both in the cytoplasm and dendrites whereas GM2 showed punctuate accumulation in perinuclear vesicles. Thus, subcellular sites of storage were also different between GM1 and GM2 in NPC neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578853     DOI: 10.1016/s0387-7604(01)00252-2

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  12 in total

1.  Longitudinal Changes in White Matter Fractional Anisotropy in Adult-Onset Niemann-Pick Disease Type C Patients Treated with Miglustat.

Authors:  Elizabeth A Bowman; Dennis Velakoulis; Patricia Desmond; Mark Walterfang
Journal:  JIMD Rep       Date:  2017-07-15

2.  An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.

Authors:  Andrew B Munkacsi; Fannie W Chen; Matthew A Brinkman; Katsumi Higaki; Giselle Domínguez Gutiérrez; Jagruti Chaudhari; Jacob V Layer; Amy Tong; Martin Bard; Charles Boone; Yiannis A Ioannou; Stephen L Sturley
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

3.  Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.

Authors:  Sharon Zhou; Cristin Davidson; Robert McGlynn; Gloria Stephney; Kostantin Dobrenis; Marie T Vanier; Steven U Walkley
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

Review 4.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

Review 5.  Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management.

Authors:  Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

6.  Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.

Authors:  Susi Anheuser; Bernadette Breiden; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

7.  Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-Pick disease type C patients treated with miglustat.

Authors:  Elizabeth A Bowman; Mark Walterfang; Larry Abel; Patricia Desmond; Michael Fahey; Dennis Velakoulis
Journal:  J Neurol       Date:  2015-06-20       Impact factor: 4.849

8.  Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice.

Authors:  Federica Scandroglio; Jagadish Kummetha Venkata; Nicoletta Loberto; Simona Prioni; Edward H Schuchman; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

9.  Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.

Authors:  Junichiro Matsuda; Osamu Suzuki; Akihiro Oshima; Yoshie Yamamoto; Akira Noguchi; Kazuhiro Takimoto; Masayuki Itoh; Yuji Matsuzaki; Yosuke Yasuda; Seiichiro Ogawa; Yuko Sakata; Eiji Nanba; Katsumi Higaki; Yoshimi Ogawa; Lika Tominaga; Kousaku Ohno; Hiroyuki Iwasaki; Hiroshi Watanabe; Roscoe O Brady; Yoshiyuki Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

10.  Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.

Authors:  Barry Boland; David A Smith; Declan Mooney; Sonia S Jung; Dominic M Walsh; Frances M Platt
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.